Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Stocks - Wall Street Extends Recovery as Reopening Plans Lift Spirits

Published 04/28/2020, 09:19 AM
Updated 04/28/2020, 09:36 AM
© Reuters.
US500
-
DJI
-
CAT
-
KO
-
MRK
-
MMM
-
AMZN
-
XOM
-
UPS
-
PEP
-
CL
-
TSLA
-
IXIC
-
BP
-

By Geoffrey Smith 

Investing.com -- U.S. stock markets pared early gains Tuesday as a barrage of downbeat earnings reports and gloomy economic data curbed the enthusiasm of those betting on a sharp rebound for the U.S. economy next month.  

By 10:30 AM ET (1430 GMT), the Dow Jones Industrial Average was up 130 points, or 1.5% at 24,264, having earlier hit a seven-week high of 24,512 points. The S&P 500 was up 0.5% and the Nasdaq Composite was down 0.2%, as the froth came out of stocks such as Amazon.com (NASDAQ:AMZN) and Tesla (NASDAQ:TSLA).

The market had earlier appeared to give U.S. Inc a pass on a quarter where results largely reflected business before the Covid-19 pandemic struck, and where visibility regarding the rest of the year has dwindled to near zero. 

Stocks weakened after the sharpest drop in the Conference Board's consumer confidence index in years, down to its lowest level since 2014.  

On a heavy morning for corporate earnings, 3M Company (NYSE:MMM) stock rose 4.2% after the company said a surge in demand for its health-care products (including face-masks) offset a decline in sales at its other divisions, which were all negatively affected by the pandemic. The company said it would cut its capital spending by over 20% this year to preserve cash. 

At the other end of the scale, United Parcel Service  (NYSE:UPS) stock fell 4.3% after the company was unable to translate a surge in demand for delivery services into higher margins due to an even sharper rise in costs.

Likewise, Merck (NYSE:MRK) stock fell 3.5% after the pharma giant warned that the pandemic could take over $2 billion off full-year sales as health care systems around the world de-prioritize some of the ailments that its best-selling drugs treat - notably its blockbuster Keytruda. The company also suspended its buyback program. 

Caterpillar (NYSE:CAT) stock rose 1.2% after a quarterly update that added little to existing knowledge, while PepsiCo  (NASDAQ:PEP) stock rose 1.3% after its first quarter was rescued by locked-down consumers' demand for snacks - an element that was missing from rival Coca-Cola (NYSE:KO)'s disappointing update last week.

Elsewhere, Exxon Mobil (NYSE:XOM) stock rose 2.2% to its highest in seven weeks after the volatility in the U.S. crude futures strip receded. Sentiment towards oil major was helped by the sight of BP (NYSE:BP) maintaining its quarterly dividend, even at the expense of a sharp rise in debt.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.